SurgiQuest, which markets a medical system that enhances access in laparoscopic surgery, filed on Tuesday with the SEC to raise up to $75 million in an initial public offering. The previous two medical device companies to go public, NovoCure (NVCR) and...read more
When there's trouble in the markets, IPO investors can rely on unprofitable, early-stage health care companies. The IPO market ended its annual end-of-summer lull as ...read more
Penumbra, which markets devices for the treatment of strokes and other vascular conditions, raised $120 million by offering 4.0 million shares at $30. It had originally planned to offer 3.8 million shares at a range of $25 to $28. Penumbra plans to...read more
After three weeks without any deals, the US IPO market is back in session. Three health care companies are each set to raise about $100 million in the week ahead....read more
The IPO surge: SurgiQuest files for a $75 million IPO
SurgiQuest, which markets a medical system that enhances access in laparoscopic surgery, filed on Tuesday with the SEC to raise up to $75 million in an initial public offering. The previous two medical device companies to go public, NovoCure (NVCR) and...read more
US IPO Weekly Recap: Health care goes three for three as IPOs trade up 30%
When there's trouble in the markets, IPO investors can rely on unprofitable, early-stage health care companies. The IPO market ended its annual end-of-summer lull as ...read more
Strike back against strokes: Penumbra prices upsized IPO above the range at $30
Penumbra, which markets devices for the treatment of strokes and other vascular conditions, raised $120 million by offering 4.0 million shares at $30. It had originally planned to offer 3.8 million shares at a range of $25 to $28. Penumbra plans to...read more
Week ahead: 3 health care IPOs set to price during the week of September 14
After three weeks without any deals, the US IPO market is back in session. Three health care companies are each set to raise about $100 million in the week ahead....read more